Aptevo Therapeutics Inc. Current Liabilities
Aptevo Therapeutics Inc. (APVO) had Current Liabilities of $5.19 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $5.19M.
- 2026-03-31: Liabilities, Current $4.76M.
- 2025-12-31: Liabilities, Current $6.05M.
- 2025-09-30: Liabilities, Current $5.61M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $5.19M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.76M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $6.05M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $5.61M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $4.89M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $5.39M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $6.21M 10-K · filed 2026-03-26 |
| 2024-09-30 | $5.88M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $5.42M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $6.30M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $7.22M 10-K · filed 2025-02-14 |
| 2023-09-30 | $6.84M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $6.91M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $5.80M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $8.71M 10-K · filed 2024-03-05 |
| 2022-09-30 | $7.79M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $7.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $23.86M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $34.76M 10-K · filed 2023-03-30 |
| 2021-09-30 | $32.38M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $30.86M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $29.34M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $14.54M 10-K · filed 2022-03-24 |
| 2020-09-30 | $7.42M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $7.00M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $6.99M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $38.24M 10-K · filed 2021-03-31 |
| 2019-09-30 | $37.25M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $16.60M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $18.29M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $17.61M 10-K · filed 2020-03-25 |
| 2018-09-30 | $15.44M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $18.10M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $17.27M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $18.51M 10-K · filed 2019-03-18 |
| 2017-09-30 | $14.87M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $11.88M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $14.46M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $19.54M 10-K · filed 2018-03-13 |
| 2016-09-30 | $15.23M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $17.03M 10-Q/A · filed 2016-09-22 |
| 2015-12-31 | $19.94M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |